🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Previously untreated CD20 positive diffuse large B-cell lymphoma (DLBCL) re...
Status
Completed
Location
Southampton University Hospitals NHS Tust
Start Date
2017-06-02
Trial ID
NCT03571308
Treatments Being Tested
The primary objective of this study is to evaluate the safety of zanubrutin...
Status
Completed
Location
Rocky Mountain Cancer Centers (Williams) Usor
Start Date
2019-10-15
Trial ID
NCT04116437
Treatments Being Tested
Background. Zanubrutinib and acalabrutinib are both associated with an incr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-22
Trial ID
NCT07283965
Treatments Being Tested
This study will be a 2-part, open-label, single-center relative bioavailabi...
Status
Completed
Location
Research Site
Start Date
2020-06-24
Trial ID
NCT04488016
Within this exploratory multicohort phase II trial, SAKK aims to evaluate a...
Status
Active Not Recruiting
Location
Ospedale Papa Giovanni XXIII
Start Date
2021-06-25
Trial ID
NCT04604067
Treatments Being Tested
This phase II trial studies how well acalabrutinib works in treating patien...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2020-12-11
Trial ID
NCT04198922
Treatments Being Tested
The goal of this clinical trial is to study the addition of Acalabrutinib t...
Status
Recruiting
Location
Saarland University Medical Center
Start Date
2023-06-07
Trial ID
NCT05820841
Treatments Being Tested
This is a Phase 1/2, study evaluating IOV-2001 (Adoptive Cell Therapy) comp...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2020-02-19
Trial ID
NCT04155710
Treatments Being Tested
This study is being done to evaluate the safety, tolerability and antitumor...
Status
Terminated
Location
City of Hope National Medical Center
Start Date
2020-10-06
Trial ID
NCT04477291
Treatments Being Tested
To evaluate the safety and tolerability and determine the recommended phase...
Status
Active Not Recruiting
Location
Shang-Ju Wu
Start Date
2021-02-22
Trial ID
NCT04688151
Treatments Being Tested